Home/Nanopath/Alison Burklund, PhD

AB

Alison Burklund, PhD

Co-Founder, Co-CEO, Board Director

Therapeutic Areas

Women's Health Infectious Disease

Nanopath Pipeline

Drug	Indication	Phase
Women's Health Diagnostic Platform	Likely syndromic panels for infections (e.g., STIs, UTIs)	Development

Leadership Team at Nanopath

Amogha Tadimety, PhD

Co-Founder, Co-CEO, Board Director

Edward Evantash, MD

Chief Medical Officer

Matthew Black, PhD

Chief Scientific Officer

View full Nanopath profile